A Case Series Examining the 1-year Follow-up Outcomes of Myocarditis Associated with COVID-19 Vaccination
Despite the seemingly benign nature of COVID-19 mRNA vaccine-related myocarditis thus far, it is crucial to emphasize the necessity of prolonged clinical and CMR follow-up exceeding 1 year. Extended monitoring is essential to gain a deeper understanding of the true nature of this condition and its potential implications. This comprehensive approach will contribute significantly to ensuring the ongoing safety and efficacy of COVID-19 vaccination programs.
Authors
- Nidal Asaad (ORCID: https://orcid.org/0000-0001-7637-9721)
- Tahir Hamid (ORCID: https://orcid.org/0000-0002-5339-159X)
- Awad Al Qahtani
- Emad M. Hassan (ORCID: https://orcid.org/0000-0003-0634-2397)
- Maryam Al Kuwari
- Sabir Abdul Karim
- Jassim Al Suwaidi (ORCID: https://orcid.org/0000-0002-5299-9106)
- Ammar Chapra (ORCID: https://orcid.org/0000-0001-9221-0328)
- Mohammed T. Ali (ORCID: https://orcid.org/0000-0002-8318-4858)
- Abdel Naser Ghareeb
- Samah Mohamed
Institutions
- Cairo University (EG)
- Al-Azhar University (EG)
- The Rotherham NHS Foundation Trust (GB)
- Hamad Medical Corporation (QA)
Publication Details
- Journal
- Heart Views
- Published
- 2024-10-01
- DOI
- https://doi.org/10.4103/heartviews.heartviews_62_24
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00